Brean Capital Boosts Onyx Pharma (ONXX) Price Target to $160
Go back to Brean Capital Boosts Onyx Pharma (ONXX) Price Target to $160| Amgen Inc (NASDAQ: AMGN) | Delayed: 439.33 +5.60 (1.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $433.73 | 52 Week High | $176.85 | |||
| Open | $431.72 | 52 Week Low | $133.64 | |||
| Day High | $440.51 | P/E | 66.16 | |||
| Day Low | $429.38 | EPS | $6.64 | |||
| Volume | 2,114,678 | |||||
| Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) | Delayed: 124.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.70 | 52 Week High | $136.87 | |||
| Open | $124.70 | 52 Week Low | $68.12 | |||
| Day High | $124.70 | P/E | N/A | |||
| Day Low | $124.70 | EPS | $-1.58 | |||
| Volume | 514,854 | |||||
